They were removed because the original nominators withdrew their nominations, which allowed the FDA to refer them to the Pharmacy Compounding Advisory Committee (PCAC) for formal review
Tirzepatides Proven Impact Tirzepatide has demonstrated robust clinical benefits in multiple large-scale trials
For patients with contraindications to GLP-1 receptor agonists, numerous effective alternatives exist for managing type 2 diabetes and obesity
4.4 Japan: PMDA The PMDA has historically required comparability studies against locally sourced reference products, which adds cost and time for biosimilar developers who have already compared against US- or EU-sourced reference products
This agonist triggers the natural hormone our bodies produce that helps us feel full after eating, leading to less frequent hunger cues, a slower digestive rate, and, potentially, fewer blood sugar changes
Bito T, Nishigori C